In Nederland heeft bijna 20 % van de volwassenen ooit te maken gehad met een depressie. Vaak wordt er dan gekeken naar de serotoninebeschikbaarheid. Maar ook de beschikbaarheid van GABA-neuronen en verbetering van de functionaliteit van de HPA-as kunnen een belangrijke rol spelen.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Trefwoorden:
Figuren
Verschenen in
Referenties
Swaab DF, Bao AM, Lucassen PJ. Ageing Research Reviews 4: 141–194, 2005
O'Toole SM, Sekula LK, Rubin RT. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression. Biological Psychiatry. 42(2):85, 1997
Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res. 35(2): 83-94, 2001
Posener JA et al. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry 57(8):755-60, 2000
Keller J et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry 60(3): 275-281, 2006
Schildkraut JJ et al. Excretion of 3-Methoxy-4-Hydroxymandelic Acid (Vma) in Depressed Patients Treated With Antidepressant Drugs. J Psychiatr Res 2: 257-266, 1964
Schildkraut JJ. The catecholamine hypothesis of affective disorders: A review of supporting evidence. J Neuropsychiatry Clin Neurosci 7: 524–533, 1965
Coppen A. The Biochemistry of Affective Disorders. The British Journal of Psychiatry 11(504): 1237-1264, 1967
Lacasse LR, Leo J. Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature. PLoS Medicine 2(12), 2005
Valenstein ES. Blaming the Brain: The Real Truth About Drugs and Mental Health. The Free Press NY, 1998
Moncrieff J, Wessely S, Hardy R. Active placebos versus antidepressants for depression. Cochrane Database of Systematic Reviews 1, 2004
Wilkinson P, Izmeth Z. Continuation and maintenance treatments for depression in older people. Cochrane Database of Systematic Reviews 11, 2012
Hazell P, Mirzaie M. Tricyclic drugs for depression in children and adolescents. Cochrane Database of Systemic Reviews 6, 2013
Jakobsen JC et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry 17:58, 2017
Savitz JB, Drevets WC. Neuroreceptor imaging in depression. Neurobiology of Disease 52: 49–65, 2013
Lloyd KG et al. Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brain stem of suicide victims an control patients. Adv Biochem Psychopharmacol 11: 387-397, 1974
Mann JJ, Malone KM. cerebrospinal Fluid Amines and Higher-Lethality Suicide Attemps in Depressed Inpatients. Biol Psychiatry 41: 161-171, 1997
Coccaro EF et al. Serotonin and impulsive aggression. CNS Spectrums 20: 295–302, 2015
Narvaes R, Martins de Almeida RM. Aggressive behavior and three neurotransmitters: dopamine, GABA, and serotonin—a review of the last 10 years. Psychology & Neuroscience, 7(4): 601-607, 2014
Rosell DR, Siever LJ. The Neurobiology of Aggression and Violence. CNS Spectrums 20: 254–279, 2015
Treadway MT and Pizzagalli DA. Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis. Biology of Mood & Anxiety Disorders 4:5, 2014
Liu et al. Chronic stress impairs GABAergic control of amygdala through suppressing the tonic GABAA receptor currents. Molecular Brain 7:32, 2014
McEwen BS.Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin Neurosci. 8: 367-381, 2006
Booij L et al. Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress–diathesis model of depression. Phil Trans R Soc B 368, 2013
